Share This Author
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia
- G. A. H. van den Elsen, Amir I. A. Ahmed, M. O. Olde Rikkert
- Medicine, PsychologyNeurology
- 9 June 2015
This study provides Class I evidence that for patients with dementia-related NPS, low-dose THC does not significantly reduce NPS at 21 days, though it is well-tolerated, which adds valuable knowledge to the scarce evidence on THC in dementia.
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
- Amir I. A. Ahmed, G. A. H. van den Elsen, M. O. Olde Rikkert
- Medicine, BiologyPsychopharmacology
- 11 March 2015
THC was rapidly absorbed and had dose-linear pharmacokinetics with considerable interindividual variation, and Pharmacodynamic effects, including adverse events, were minor.
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial.
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
Neuropsychiatric Adverse Events of Varenicline: A Systematic Review of Published Reports
- Amir I. A. Ahmed, A. Ali, C. Kramers, L. Härmark, D. Burger, W. Verhoeven
- Medicine, PsychologyJournal of clinical psychopharmacology
- 1 February 2013
Varenicline is associated with an increased risk of serious neuropsychiatric AEs, especially in patients with a psychiatric illness, and it is strongly recommended that vareniclines be administered only to mentally stable patients and under close monitoring.
Potentially inappropriate prescribing in older patients admitted to psychiatric hospital
- S. Rongen, C. Kramers, D. O’Mahony, T. Feuth, M. O. Olde Rikkert, Amir I. A. Ahmed
- Medicine, PsychologyInternational journal of geriatric psychiatry
- 1 February 2016
The objectives of this study are to determine the prevalence of potentially inappropriate prescribing including potentially inappropriate medications (PIMs) and potential prescription omissions…
A man who wanted to commit suicide by hanging himself: an adverse effect of ciprofloxacin.
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial
- G. A. H. van den Elsen, Lieke Tobben, M. A. van der Marck
- Medicine, PsychologyJournal of psychopharmacology
- 1 February 2017
This study showed that 3 mg of THC per day has a benign adverse event profile regarding mobility and was well tolerated by community-dwelling dementia patients.
Medicinal Use of Cannabis and Cannabinoids in Older Adults: Where Is the Evidence?
- Amir I. A. Ahmed, G. V. D. Elsen, M. Marck, M. O. Olde Rikkert
- Medicine, BiologyJournal of the American Geriatrics Society
- 1 February 2014
Her physical examination revealed rales and decreased breath sounds on the right and bilateral expiratory wheezes, and she was admitted to the medical intensive care unit for respiratory support and started on moxifloxacin for a presumed infectious process.